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Acne vulgaris is potentially a severe skin disease associated with colonization of the pilo-sebaceous unit by the
commensal bacterium Propionibacterium acnes and inflammation. P. acnes is considered to contribute to
inflammation in acne, but the pathways involved are unclear. Here we reveal a mechanism that regulates
inflammatory responses to P. acnes. We show that IL-1b mRNA and the active processed form of IL-1b are
abundant in inflammatory acne lesions. Moreover, we identify P. acnes as a trigger of monocyte–macrophage
NLRP3-inflammasome activation, IL-1b processing and secretion that is dependent on phagocytosis, lysosomal
destabilization, reactive oxygen species, and cellular Kþ efflux. In mice, inflammation induced by
P. acnes is critically dependent on IL-1b and the NLRP3 inflammasome of myeloid cells. These findings show
that the commensal P. acnes—by activating the inflammasome—can trigger an innate immune response in the
skin, thus establishing the NLRP3-inflammasome and IL-1b as possible therapeutic targets in acne.
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INTRODUCTION
Acne vulgaris is a chronic inflammatory disease of the pilo-
sebaceous unit. It is the most common skin disease, affecting
approximately 80% of individuals at some time during their
lives (Williams et al., 2012). The disease is multifactorial, and
four processes are considered to have a pivotal role in the
formation of acne lesions, namely, increased sebum
production; altered follicular keratinization; inflammation;
and bacterial colonization of the pilo-sebaceous unit by
Propionibacterium acnes (Leeming et al., 1988; Leyden
et al., 1998). Androgen-induced increased sebum production
and follicular hyperkeratinization/plugging are thought to be
the initial steps leading to a change of the pilo-sebaceous
milieu that favors proliferation of P. acnes (Kurokawa et al.,
2009). Extensive P. acnes overgrowth in the microcomedone
is associated with inflammation of the pilo-sebacious follicle.
(Toyoda and Morohashi, 2001; Degitz et al., 2007). Pro-
inflammatory cytokines, including IL-1a and tumour necrosis
factor a (TNFa), are, among others, considered to date to be
responsible for the further follicular hyperkeratinization and
the inflammatory lesions characteristic of acne (Gollnick, 2003;
Zouboulis et al., 2005; Kurokawa et al., 2009). Controversy
exists, however, concerning the significance of the commensal
P. acnes in the development of acne (Kurokawa et al., 2009;
Fitz-Gibbon et al., 2013). It has been suggested that P. acnes
may contribute to the development of inflammatory lesions by
releasing chemotactic substances, and stimulating the secretion
of IL-6 and IL-8 by follicular keratinocytes, and IL-1b, TNFa,
IL-8, and IL-12 by monocytic cells (Leeming et al., 1988;
Vowels et al., 1995; Bojar and Holland, 2004; Kurokawa
et al., 2009). Direct evidence of relevant triggers of
inflammation in acne in vivo, and the precise molecular
mechanisms involved, remain, however, largely unknown.
Innate immunity is our first line of defense against patho-
gens (pathogen-associated molecular patterns (PAMPs)) and
danger (danger-associated molecular patterns (DAMPs)).
Responses to PAMPs and DAMPs are mediated by germ-line
encoded pattern-recognition receptors (PRRs). Among the
PRRs, certain Nod-like receptor (NLR) family members,
including NLRP1, NLRP3, NLRC4, and AIM2, have the ability
to mediate responses to PAMPs and DAMPs and subsequently
assemble to form high-molecular weight, caspase-1-activating
molecular platforms called inflammasomes, which control the
activation and secretion of the pro-inflammatory cytokines
IL-1b and IL-18 (Martinon et al., 2009; Feldmeyer et al., 2010).
Based on the observations that deregulation of the inflam-
masome and IL-1b has been linked to a rare genetic auto-
inflammatory syndrome associating pyogenic arthritis,
pyoderma gangrenosum, and acne, named the PAPA syn-
drome (Yu et al., 2007) and, furthermore, that acne is
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characterized by neutrophilic infiltration of the skin, a
distinctive feature observed in transgenic mice carrying a
mutation in the NLRP3 gene equivalent to the human
mutation associated with Muckle–Wells Syndrome (Meng
et al., 2009), we considered that the inflammasome and
IL-1b may be directly involved in the pathogenesis of acne.
In this work, we show that the pro-inflammatory cytokine
IL-1b is abundant in its active form in human acne lesions and
that the production of IL-1b by P. acnes-exposed cells of
monocytic lineage requires activation of the NLRP3-inflam-
masome. We also demonstrate that P. acnes infection triggers
strong inflammatory responses in mice in a NLRP3-inflamma-
some-dependent manner. Altogether, our data implicate IL-1b
as a novel potential therapeutic target in acne.
RESULTS
P. acnes induces IL-1b secretion in monocytic cells
We assessed in situ IL-1b production in human acne lesions by
immuno-histochemistry. The active, processed form of IL-1b
was at the site of cutaneous inflammation, notably together
with macrophages surrounding the pilo-sebaceous unit
(Figure 1a and Supplementary Figure S1 online). Accordingly,
we detected elevated levels (450 mean fold increase) of IL-1b
mRNA (Figure 1b) selectively in skin biopsies of papulo-
pustular acne. To test whether P. acnes is a pro-inflammatory
trigger for IL-1b production observed in acne lesions, human
monocytes were exposed to live or heat-inactivated P. acnes
in vitro. Within 24 hours of exposure to P. acnes, significant
pro-IL-1b synthesis and subsequent mature-IL-1b secretion
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Figure 1. P. acnes induces cytokine secretion from human myeloid cells. (a) Mature-IL-1b expression in human sections of papulo-pustular acne or normal
skin. Bottom left panel, high magnification. Bar¼100mM. (b) Quantitative PCR of IL-1b in acne (AV, n¼ 12) and normal skin (NS, n¼ 6). Relative IL-1b
abundance against RPL27 analyzed and normalized with average of normal skin. (c) Monocytes exposed to live or heat-inactivated (HI) P. acnes
(multiplicity of infection (MOI)¼ 100). Western blotting of pro- and mature-IL-1b-p17 in lysates and supernatants (SN), respectively. (d–g) Monocytes
stimulated with live or HI P. acnes for 24 hours. IL-1b, IL-6, tumor necrosis factor-a (TNFa), and IL-8 release was determined by ELISA. (h) ELISA of IL1-b
secreted from ultra-pure lipopolysaccharide (upLPS)-primed monocytes exposed to P. acnes. (i) IL-1b ELISA of P. acnes-exposed or UVB-irradiated
keratinocytes supernatant. Results are mean±SD, representative of three experiments. **Pp0.001; ***Pp0.0001; ****Pp0.00001. NS, not significant.
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could be detected by western blotting in cell lysates and cell
culture supernatants, respectively (Figure 1c). Moreover, expo-
sure of monocytes to live or heat-inactivated P.acnes led to the
secretion of IL-1b, IL-6, TNFa, and IL-8 in a multiplicity of
infection (MOI)-dependent manner (Figure 1d–g). Interest-
ingly, monocytes secrete nanograms of IL-1b within 24 hours
of P. acnes exposure (Figure 1d), without the requirement for
pre-stimulation with ultra-pure lipopolysaccharide (upLPS),
suggesting that P. acnes triggering of IL-1b production is
biologically relevant as picograms of IL-1b are known to be
already active in vivo (Dinarello, 1996).
Previous induction of pro-IL-1b synthesis (signal-1) by pre-
stimulation of myeloid cells with upLPS or phorbol-12-
myristate-13-acetate resulted in stronger IL-1b secretion upon
P. acnes exposure (Figure 1h and Supplementary Figure S2
online). Although keratinocytes are able to sense certain
DAMPs and subsequently drive IL-1b-dependent innate
immune responses in the skin (Feldmeyer et al., 2007;
Watanabe et al., 2007, 2008), they were unable to secrete
mature IL-1b when exposed to P. acnes alone or in the
presence of monocyte-conditioned medium (Figure 1i and
Supplementary Figure S3 online). Keratinocytes were also
unable to secrete IL-6 and TNFa upon P. acnes exposure but
did secrete low levels of IL-8 when exposed to very high MOI
of live P. acnes (Supplementary Figure S4 online).
Taken together, the above experiments suggest that cells of
myeloid origin are primarily involved in the detection of P.
acnes that leads to the mature IL-1b production occurring in
the inflammatory acne lesions of the skin.
P. acnes induces IL-1b secretion in a NLRP3-inflammasome-
dependent manner
Enzymatic processing of the inactive precursor of IL-1b (pro-
IL-1b) by caspase-1 and subsequent secretion of mature IL-1b
are essential steps required for its function. Caspase-1 is
initially expressed as an inactive precursor, which can be
activated by the inflammasome, a cytoplasmic multiprotein
complex composed of a NLRP family member, apoptosis-
associated speck-like protein containing CARD (ASC), and
caspase-1 (Martinon et al., 2002). In P. acnes-exposed human
monocytes, the secretion of IL-1b could be inhibited in the
presence of the caspase inhibitor Z-VAD (Figure 2a). More-
over and in spite of normal pro-IL-1b levels (Supplementary
Figure S5c online), THP1 cells transfected with caspase-1-
shRNA (Figure 2b and Supplementary Figure S5a online) and
bone marrow–derived dendritic cells (BMDC) from caspase-1-
deficient mice (Casp1 / ) (Figure 2e) were unable to secrete
IL-1b either upon P. acnes exposure or stimulation with the
inflammasome activators monosodiumurate crystals (MSU) or
nigericin (Supplementary Figure S5d online). In contrast,
monocyte production of IL-6, TNFa, and IL-8 was not
inhibited by Z-VAD, demonstrating that the secretion of these
cytokines upon P. acnes exposure is independent of inflam-
masome activation and IL-1b signaling (Supplementary Figure
S6 online). Furthermore, THP1 cells transduced with ASC-
shRNA (Figure 2c and Supplementary Figure S5a online) or
NLRP3-shRNA (Figure 2d and Supplementary Figure S5a
online) also exhibited reduced IL-1b secretion upon P. acnes
exposure, whereas pro-IL-1b synthesis was not affected (Supple-
mentary Figure S5e online). To further demonstrate the role of
the inflammasome in P. acnes-induced IL-1b secretion, we also
exposed BMDC from mice deficient for ASC (Asc / ) or
NLRP3 (Nlrp3 / ) to P. acnes. Indeed, Asc / and Nlrp3 /
BMDC exhibited strongly reduced IL-1b secretion when
compared with wild-type (WT) cells (Figure 2f and g).
Distinct bacterial components may be recognized by
different inflammasomes. Indeed, it has been shown
that NLRP3 and NLRC4 (Ipaf) (Sutterwala and Flavell, 2009)
are also able to sense certain bacterial components. In contrast
to the NLRP3-inflammasome, the NLRC4-inflammasome
does not appear to be involved in P. acnes-induced
IL-1b production by BMDC (Supplementary Figure S7a
online). Furthermore, using shRNA-transduced THP1 cells
(Supplementary Figure S5b online), we observed that NLRP1
is also dispensable for IL-1b secretion upon P. acnes exposure
(Figure 2d). Interestingly, and in concordance with the above
observations, expression analysis in human acne biopsies
revealed increased levels of NLRP3 mRNA as compared
with the normal skin, whereas the mRNA expression levels
of NLRP1 and NLRC4 were not altered (Figure 2h and
Supplementary Figure S7b online). Importantly, in acne skin
biopsies the levels of NLRP3 mRNA correlated significantly
with the levels of IL-1b mRNA (Figure 2i).
These data demonstrate that P. acnes is a potent activator of
the NLRP3-inflammasome in cells of monocytic lineage.
P. acnes-induced NLRP3-inflammasome activation depends on
bacteria uptake, lysosomal maturation, reactive oxygen species
(ROS), and potassium efflux
Current models of NLRP3-inflammasome activation include
the generation of ROS (Cruz et al., 2007; Petrilli et al., 2007;
Dostert et al., 2008), potassium efflux (Petrilli et al., 2007),
and lysosomal damage with release and activation of
cathepsin B for stimuli-requiring phagocytosis, such as MSU
and silica (Dostert et al., 2008; Hornung et al., 2008).
Exposure of THP1 cells to cytochalasin D (Cyt. D), an
inhibitor of actin filament assembly, abrogated the uptake of
P. acnes (Figure 3a). Likewise, IL-1b maturation and secretion
in upLPS-stimulated monocytes exposed to P. acnes or MSU
was reduced by Cyt. D, whereas the response to the non-
crystalline NLRP3-inflammasome activator nigericin was not
affected (Figure 3b). Interestingly, both pro-IL-1b synthesis and
IL-1b release from non-upLPS-stimulated monocytes exposed
to P. acnes were impaired by Cyt. D (Figure 3c). These
observations demonstrate that internalization of the bacteria
by antigen-presenting cells is essential for both pro-IL-1b
synthesis (signal-1) and its cleavage into the active, secreted
form of IL-1b (signal-2). Furthermore, specific blockade of the
lysosomal cysteine protease cathepsin B, but not cathepsin D,
resulted in decreased IL-1b secretion by P. acnes- or silica-
exposed monocytes (Figure 3d), showing that lysosomal
rupture is also required for IL-1b secretion in response to
P. acnes. In contrast, none of the cathepsin inhibitors affected
IL-1b release upon exposure to exogenous ATP.
To analyze further mechanism(s) possibly leading to
NLRP3-inflammasome activation upon P. acnes exposure,
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we pre-treated human monocytes with upLPS to induce
generation of pro-IL-1b and subsequently exposed them to
P. acnes in the presence of ROS inhibitors, namely dipheny-
leneiodonium or ammonium pyrrolidinedithiocarbamate.
Under these conditions, IL-1b secretion by monocytes
exposed to P. acnes or MSU was reduced by the ROS
inhibitors (Figure 3e). It has been previously shown that
triggering of ROS in human granulocytes is caused by
potassium efflux (Fay et al., 2006). Inhibiting Kþ efflux,
either by increased extracellular potassium concentration or
by blockade of potassium channels with glibenclamide
(Muruve et al., 2008) also resulted in a significant reduction
of IL-1b release by P. acnes- or MSU-exposed monocytes
(Figure 3f), whereas TNFa secretion was unaffected
(Figure 3g). We also assessed whether cellular ATP has a role
in P. acnes-induced IL-1b production. BMDC from ATP
receptor P2X7 / mice released similar amounts of IL-1b as
BMDC from WT mice when exposed to P. acnes or MSU,
whereas failing to respond to ATP (Figure 3h). This suggests
that P. acnes did not induce ATP release from exposed
monocytic cells.
Taken together, these data demonstrate that inflammasome
activation and the secretion of mature IL-1b by monocytes
upon exposure to P. acnes requires phagocytosis, lysosomal
damage with release, and activation of cathepsin B, genera-
tion of ROS, and potassium efflux.
P. acnes induces NLRP3-inflammasome-dependent IL-1b
production and inflammation in vivo
We next assessed whether the NLRP3-inflammasome is
involved in sensing P. acnes in vivo, and whether IL-1b has
a role in P. acnes-associated inflammation. To mimic the
inflammatory response occurring in human acne upon folli-
cular rupture and, as previously described, we injected live
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live P. acnes, or monosodiumurate crystals (MSU) in the presence of DMSO or Z-VAD-fmk for 24 hours. IL-1b and mature-IL-1b levels determined in supernatants
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P. acnes intradermally into mouse ears (Toyoda and Morohashi,
2001; Nakatsuji et al., 2011). The injection of P. acnes in the
ears of WT mice resulted in significant ear swelling within
24 hours (Figure 4a), production of pro- and mature-IL-1b
(Figure 4b), and a strong inflammatory response histologically
comprised primarily of neutrophils (Figure 4c). When inflam-
masome-deficient Asc / mice were compared with WT
mice after intradermal injection of P. acnes, ear swelling
(Figure 4a), production of pro- and mature-IL-1b (Figure 4b),
as well as inflammation (Figure 4c), were all reduced. In
Nlrp3 / mice, the magnitude of ear swelling and production
of IL-1b were also reduced, similarly to Asc / mice
(Figure 4a and b). These observations are consistent with our
in vitro data and indicate that NLRP3-inflammasome-depen-
dent IL-1b triggers neutrophilic inflammatory lesions at the site
of P. acnes infection. To further verify this hypothesis,
P. acnes-injected mice were treated intraperitoneally (i.p.) with
an IL-1 receptor antagonist (IL-1Ra), a monoclonal anti-IL-1b
antibody, or a TNFa inhibitor (etanercept) before intradermal
administration of P. acnes. A significant reduction in ear
swelling and inflammation were observed in IL-1Ra- and
anti-IL-1b-treated mice as compared with TNFa inhibitor–
treated mice (Figure 4c and d), thus confirming the crucial and
selective role of IL-1b in the generation of cutaneous inflam-
mation in response to P. acnes in vivo. In accordance with
these findings, Il-1rI / mice also exhibited significantly
reduced ear swelling after P. acnes injection (Figure 4e).
To determine which cell types are required for triggering
IL-1b-dependent inflammation upon P. acnes infection in vivo,
we generated bone marrow chimeras consisting of WT mice
reconstituted with either WT, Asc / , or Nlrp3 / bone
marrow. Resulting chimeras were injected intradermally with
P. acnes as above. Ear swelling (Figure 5a) and inflammatory
infiltrates (Figure 5b) were reduced in chimeric mice harbor-
ing Asc / or Nlrp3 / myeloid cells when compared with
mice transplanted with WT bone marrow. Moreover, the
in vivo response to P. acnes was restored when Asc / or
Nlrp3 / mice were reconstituted with WT bone marrow
(Figure 5c). These data indicate that the inflammatory response
to P. acnes in vivo is mediated by cells of myeloid lineage.
This is consistent with previous reports showing that P. acnes
injection in mouse ears induced infiltrates composed of
CD11bþ cells, which were shown to phagocyte the bacteria
(Nakatsuji et al., 2011). It also excludes a significant possible
role of Langerhans cells, known to be radio-resistant, in the
P. acnes-induced in vivo inflammatory response.
Taken together, our data demonstrate that IL-1b secreted
from myeloid cells in a NLRP3-inflammasome-dependent
manner, is responsible for the induction of a neutrophilic
inflammatory response to P. acnes in vivo.
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DISCUSSION
Here, we show that the common anaerobic Gram-positive
commensal of normal skin P. acnes can modulate skin immune
responses triggered by innate immune receptors. Indeed, the
high levels of IL-1b observed in human acne lesions and in
mouse skin lesions induced by P. acnes suggest that the
sensing of P. acnes in vivo is a critical event in the exacer-
bation of inflammatory skin lesions via a mechanism involving
NLRP3-inflammasome activation in myeloid cells. The in vitro
role of NLRP3-inflammasome in IL-1b secretion upon P. acnes
exposure has also been recently reported by Qin et al. (2013).
To date, the exact molecular mechanisms leading to
NLRP3-inflammasome oligomerization and activation are
not fully understood. In contrast to most innate PRRs, includ-
ing Toll-like receptors, the NLRP3-inflammasome can be
activated by quite a large variety of structurally distinct signals
among which are DAMPs, PAMPs, and certain bacterial toxins
(Strowig et al., 2012). Consistent with this, infection with
several pathogenic bacteria has been reported to induce
NLRP3-inflammasome activation, including intracellular
bacteria such as Mycobacterium tuberculosis (Mishra et al.,
2010). Several models have been proposed to explain how
such diverse NLRP3-activating signals can lead to selective
NLRP3-inflammasome assembly (Strowig et al., 2012). These
include the ROS generation, Kþ efflux, and lysosomal rupture
models (Stutz et al., 2009). The potassium efflux and
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lysosomal rupture models account for NLRP3-inflammasome
activation during infection with Chlamydia pneumonia (He
et al., 2010), Klebsiella pneumonia (Willingham et al., 2009),
Porphyromonas gingivalis (Huang et al., 2009), or Neisseria
gonorrhoeae (Duncan et al., 2009). Here, we provide
evidence here that all three mechanisms of NLRP3-
inflammasome activation are involved in P. acnes-mediated
activation of the NLRP3-inflammasome. Notably, we show
that bacterial internalization due to phagocytosis by cells of
myeloid origin is essential for both NF-kB-dependent pro-IL1b
synthesis (signal-1) and inflammasome-dependent cleavage
into the active secreted form (signal-2). It was previously
unclear if and precisely how the commensal bacteria P. acnes
can trigger an inflammatory response. Our experiments reveal
that NLRP3 deficiency in myeloid cells is sufficient to prevent
P. acnes-induced inflammation in vivo and that P. acnes
selectively induces inflammasome activation in myeloid cells
but not in keratinocytes in vitro. This suggests that triggering
inflammation by P. acnes is dependent on location and more
specifically upon adequate access of the bacterium to myeloid
cells as well as their ability to phagocytose the bacteria and
trigger a NLRP3-inflammasome-dependent innate immune
response. Previous studies histologically assessing early
events in skin biopsies from acne patients have revealed that
macrophages are present in high numbers in the immediate
proximity of the pilo-sebaceous follicle of uninvolved acne
skin as well as in early stage inflammatory lesions (Layton
et al., 1998; Jeremy et al., 2003). Moreover, it has been shown
in skin biopsies of inflammatory acne lesions that perifollicular
macrophages contain phagocytized P. acnes (Toyoda and
Morohashi, 2001) and express caspase-1 and NLRP3-
inflammasome (Qin et al., 2013). These macrophages are
likely to serve as sentinels in acne by triggering an NLRP3-
inflammasome-dependent inflammatory response when they
gain access to P. acnes released into the perifollicular
environment following the onset of follicular rupture
provoked by follicular obstruction and P. acnes overgrowth.
The therapy of inflammatory acne can be challenging. Lack
of response, side effects, or recurrences following systemic
therapy using antibiotics or retinoids are quite frequent (James,
2005). Alternative effective therapies for acne are thus needed.
Recently, clinical reports suggesting a therapeutic effect of
drugs targeting IL-1b signaling in patients suffering from
autoinflammatory syndromes in which acne is a symptom
have appeared (Brenner et al., 2009; Braun-Falco et al., 2012;
Wendling et al., 2012). Accordingly, our data suggest that the
targeting of IL-1b production and secretion may be a
therapeutic option for acne vulgaris.
Taken together, we show that P. acnes, one of the factors
considered to contribute to acne, is a potent trigger of NLRP3-
inflammasome assembly and IL-1b production in myeloid
cells in vitro and in vivo. This observation strongly suggests
that P. acnes-induced cutaneous inflammatory responses
could be selectively prevented by targeting inflammasome
components or IL-1b. Our data thus indicate novel possible
avenues for targeted treatment of the most debilitating features
of acne, namely, painful inflammatory skin lesions and
subsequent scarring.
MATERIALS AND METHODS
Mice
Asc / C57BL/6 mice (Mariathasan et al., 2004) were obtained
from Genentech (San Francisco, CA). Nlrp3 / C57BL/6 mice
(Martinon et al., 2006) were obtained from Professor Ju¨rg Tschopp
(Biochemistry Institute, University of Lausanne, Epalinges, Switzerland).
Caspase1 / C57BL/6 (Li et al., 1995) and Nlrc4 / C57BL/6 mice
(Franchi et al., 2006) were kindly provided by Wolf-Dietrich Hardt
(Institute of Microbiology, ETH Zu¨rich, Switzerland). P2X7 / C57BL/6
(Solle et al., 2001) and Il-1rI / C57BL/6 (Glaccum et al., 1997) were
obtained from Jackson Laboratories (Bar Harbor, ME). Wild-type C57BL/
6 mice were obtained from Charles River (Sulzfeld, Germany). All the
knockouts used in this study have been backcrossed at least 10 times to
C57BL/6 background. All the experiments were approved by the local
Animal Protection Authorities.
Human skin sampling
All human skin biopsies were collected with informed written consent
upon approval of Local Ethical Committees and were conducted
according to the Declaration of Helsinki Principals.
Cells
Human THP1 promonocytic leukemia cells were grown in RPMI
1640 medium (Invitrogen, Basel, Switzerland), supplemented with
10% fetal calf serum (Invitrogen), 1% Antibiotic-Antimycotic
(Invitrogen), 1 mM sodium-pyruvate (Invitrogen), and 2 mM GlutaMAX
solution (Invitrogen).
Monocytes from healthy donors (10 different donors) were obtained
from peripheral blood mononuclear cells (PBMC). PBMC were
purified from buffy-coats (obtained from Blood Donation Center in
Schlieren, Switzerland) using a density gradient (Ficoll-Paque,
Pharmacia, Glattbrugg, Switzerland). Monocytes were sorted from
PBMC using anti-CD14-labeled magnetic beads (MACS, Miltenyi
Biotech, Bergisch-Gladbach, Germany) according to the manufac-
turer’s instructions.
Mouse BMDC were obtained by differentiation of bone marrow
cells, from 6- to 10-weeks-old mice, for 8 days in RPMI 1640 medium
supplemented like above and in the presence of 20% X-63 cells
(mGM-CSF-producing cells) supernatant.
Human primary keratinocytes have been cultivated as previously
described (Keller et al., 2009). Cells were irradiated with UVB
(Medisun HF-54, Schulze and Bo¨hm or UV802L, Waldmann,
Villingen-Schwenningen, Germany; 0.26 mW cm 2 for 6 minutes)
in keratinocyte–serum-free medium (Invitrogen) or exposed to live
P. acnes. In co-culture experiments, human primary keratinocytes
were stimulated with the indicated MOI of live P. acnes in the
presence of monocyte P.acnes-conditioned medium. Briefly, primary
monocytes were stimulated with live P. acnes (MOI¼ 30), condi-
tioned medium was harvested after 24 hours and applied to the
keratinocytes in the absence or presence of live P. acnes. For
infection experiments, THP1 cell were differentiated for 3 hours with
500 nM phorbol-12-myristate-13-acetate (Sigma-Aldrich, Buchs,
Switzerland), washed, and platted 1 day before stimulation; human
monocytes and mouse BMDC were primed overnight with upLPS
(E. coli 0111:B4, 100 ng ml 1, InvivoGen, San Diego, CA) in
antibiotic-free medium. Twelve hours later, medium was replaced,
and the cells were infected with live or heat-inactivated P. acnes at
the indicated MOI or stimulated with MSU (150mg ml 1), nigericin
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(20mM, Enzo Life Sciences, Lausen, Switzerland), silica (500mg ml 1,
gift by Professor J Tschopp), and Zymosan A (200mg ml 1, Sigma-
Aldrich) for the indicated time. ATP (5 mM, Sigma-Aldrich) was
added to the cells 30 minutes before collection of supernatants. All
experiments for western blotting analysis were performed in Opti-
MEM serum-free medium (Invitrogen).
The following chemical inhibitors were used: Z-VAD-fmk (Z-VAD,
10mM, Enzo Life Sciences), NADPH-oxidase inhibitor dibenziodolium
chloride (10mM, Sigma-Aldrich); NO-synthase inhibitor ammonium
pyrrolidinecarbodithioate (10mM, Sigma-Aldrich), glibenclamide
(100mM, Sigma-Aldrich), KCl (65 mM, Fluka, Buchs, Switzerland),
cathepsin B inhibitor (CA-074Me, 10mM, Calbiochem, Zug, Switzerland)
or cathepsin D inhibitor (Pepstatin A, 10mM, Sigma-Aldrich), and Cyt.
D (2.5mM, Fluka). Inhibitors were added 1 hour before cell stimulation
where applicable. Supernatants were collected after 6 hours.
Generation of THP1 cells stably expressing shRNA
THP1 cells stably expressing shRNA against lamin A/C, ASC, caspase-1,
NLRP1, and NLRP3 were obtained by transducing THP1 cells with
lentiviral particles. Briefly, gene-specific shRNA were generated by
inserting oligonucleotides targeting lamin A/C, ASC, caspase-1,
NLRP3 (Petrilli et al., 2007), or NLRP1 (Feldmeyer et al., 2007) into
pSUPER vector (Oligoengine, Seattle, WA) and subsequent cloning
into lentiviral vector pAB286.1 as described elsewhere (Petrilli et al.,
2007). Second-generation packaging plasmids pMD2-VSVG and
pCMV-R8.91 (gift by ProfessorJ Tschopp) were used for lentivirus
production and infection.
Mouse intradermal infection model
P. acnes (DMSZ 1897) was intradermally injected (20 106 in 20ml
of PBS) into the left ears of mice. Right ears were injected with an
equal volume of PBS. IL-1Ra-treated mice: C57BL/6 mice received
three i.p. injections of IL-1Ra (Anakinra, Kineret 150 mg kg 1,
Amgen, Zug, Switzerland) or PBS at 8-hour intervals. One hour after
first i.p. injection of IL-1Ra, mice received intradermal injections of P.
acnes or PBS. TNFa inhibitor (etanercept, 5 mg kg 1, Wyeth Europa,
Zug, Switzerland) or anti-IL-1b antibody (200mg per mouse, kindly
provided by Novartis, Basel, Switzerland) were injected i.p. 24 hours
before intradermal injection of P. acnes or PBS. Bone marrow
chimera: indicated mice were lethally irradiated (10 Gy) and subse-
quently transplanted with indicated bone marrow. After hematopoietic
reconstitution (8 weeks later), mice were intradermally injected with
P. acnes or PBS. The ear thickness was measured using a micro caliper
(Mitutoyo, Kawasaki, Japan) before and 24 hours after bacterial
injection. The percentage of ear thickness was calculated by compar-
ing the ear thickness before (100%) and 24 hours after injection.
Statistical analyses
The statistical analysis for quantitative PCR performed on human
samples was performed using Mann–Whitney two-tailed test. Data
obtained from in vitro experiments were subjected to one-way
analysis of variance with Bonferroni’s post-test. Data obtained from
in vivo studies were subjected to unpaired Student’s t-test. Differences
were considered significant when: *Pp0.05, **Pp0.001,
***Pp0.0001, and ****Pp0.00001. Spearman’s rank correlation
analysis was used to investigate the possible correlations between
NALP3 and IL-1b mRNA expression levels. All statistics were
performed using the GraphPad Prism software (San Diego, CA).
Full methods are available in the Supplementary Information
online.
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